nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Acknowledgement
|
|
|
|
19 |
6 |
p. 698-699 |
artikel |
2 |
An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A
|
S.-Are, Vijay |
|
|
19 |
6 |
p. 694-696 |
artikel |
3 |
A systematic review and meta-analysis of the COVID-19 associated liver injury
|
Wong, Yu Jun |
|
|
19 |
6 |
p. 627-634 |
artikel |
4 |
Body mass index and alcohol consumption are directly related with liver steatosis. Results from a prospective study of patients referred for hyperferritinemia
|
Castiella, Agustín |
|
|
19 |
6 |
p. 697 |
artikel |
5 |
Calling a stage-based treatment model for chronic liver diseases in China mainland
|
Liu, Xueqin |
|
|
19 |
6 |
p. 585-589 |
artikel |
6 |
Cerebral hemodynamics in the non-alcoholic fatty liver
|
Vidal-González, David |
|
|
19 |
6 |
p. 668-673 |
artikel |
7 |
Chemotherapy-associated steatohepatitis
|
Meunier, Lucy |
|
|
19 |
6 |
p. 597-601 |
artikel |
8 |
COVID-19 and the liver: What do we know after six months of the pandemic?
|
Fierro, Nora A. |
|
|
19 |
6 |
p. 590-591 |
artikel |
9 |
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
|
Zambrano-Huailla, Rommel |
|
|
19 |
6 |
p. 622-626 |
artikel |
10 |
Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma
|
Do, Huy Q |
|
|
19 |
6 |
p. 645-653 |
artikel |
11 |
For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!
|
Peltekian, Kevork Minas |
|
|
19 |
6 |
p. 583-584 |
artikel |
12 |
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III
|
Reja, Mishal |
|
|
19 |
6 |
p. 635-640 |
artikel |
13 |
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
|
Arab, Juan Pablo |
|
|
19 |
6 |
p. 674-690 |
artikel |
14 |
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study
|
Piñero, Federico |
|
|
19 |
6 |
p. 662-667 |
artikel |
15 |
Ocular manifestations of liver disease in children: Clinical aspects and implications
|
Prasad, Durga |
|
|
19 |
6 |
p. 608-613 |
artikel |
16 |
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases
|
Marciano, Sebastián |
|
|
19 |
6 |
p. 641-644 |
artikel |
17 |
Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis
|
He, Yong Zhu |
|
|
19 |
6 |
p. 654-661 |
artikel |
18 |
Role of CD98 in liver disease
|
Canup, Brandon S.B. |
|
|
19 |
6 |
p. 602-607 |
artikel |
19 |
SARS-CoV-2 another kind of liver aggressor, how does it do that?
|
Lozano-Sepulveda, Sonia A. |
|
|
19 |
6 |
p. 592-596 |
artikel |
20 |
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension
|
Giuffrè, Mauro |
|
|
19 |
6 |
p. 691-693 |
artikel |
21 |
staff AOHEP
|
|
|
|
19 |
6 |
p. i-ii |
artikel |
22 |
The effect of liver test abnormalities on the prognosis of COVID-19
|
Medetalibeyoglu, Alpay |
|
|
19 |
6 |
p. 614-621 |
artikel |